MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ELOX — Eloxx Pharmaceuticals, Inc. Common Stock
NasdaqEloxx Pharmaceuticals, Inc. Common Stock
$15.51
-0.20(-1.27%)
- O
- 15.92
- H
- 16.02
- L
- 14.91
- V
- 17.67K
⏱️ End-of-day dataAs of Oct 2, 2026
ELOX — Latest News & Headlines
6 StoriesEloxx Pharmaceuticals, Inc. SEC Filing (Sep 21, 2026) - Stock Titan
Eloxx Pharmaceuticals, Inc. SEC Filing (Sep 21, 2026) Stock Titan
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Short Interest Update - MarketBeat
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Short Interest Update MarketBeat
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session Benzinga
ELOX stock enters a 24 patient Phase 2b kidney trial - AD HOC NEWS
ELOX stock enters a 24 patient Phase 2b kidney trial AD HOC NEWS
Eloxx Pharmaceuticals stock falls 1.49 percent as trial focus grows - AD HOC NEWS
Eloxx Pharmaceuticals stock falls 1.49 percent as trial focus grows AD HOC NEWS
Eloxx Pharmaceuticals stock reports an Alport trial milestone - AD HOC NEWS
Eloxx Pharmaceuticals stock reports an Alport trial milestone AD HOC NEWS